Bile duct cyst

disease
On this page

Also known as bile duct cystscholedochal cystcholedochal cystscholedochocelecongenital cystic dilatation of the biliary tract

Summary

Bile duct cyst (MONDO:0018805) is a disease and 14 clinical trials. Top therapeutic interventions include etomidate, midazolam, and propofol. A subtype of bile duct disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: 1-9 / 100 000 (Worldwide) [Orphanet-validated]
  • Clinical trials: 14

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Prevalence at birth1-9 / 100 0001WorldwideValidated

Identifiers

Disease identifiers

FieldValue
Canonical namebile duct cyst
Mondo IDMONDO:0018805
MeSHD015529
OMIM603003
Orphanet480501
DOIDDOID:899
ICD-10-CMQ44.4
ICD-11819487805
SNOMED CT397868007
UMLSC0008340
MedGen3037
GARD0021973
Is cancer (heuristic)no

Also known as: bile duct cysts · choledochal cyst · choledochal cysts · choledochocele · congenital cystic dilatation of the biliary tract

Disease family

This is a subtype of bile duct disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderhepatobiliary disorderbiliary tract disorderbile duct disorderbile duct cyst

Related subtypes (6): perforation of bile duct, cholestasis, common bile duct disorder, non-neoplastic bile duct disorder, bile duct neoplasm, fibrosis of bile duct

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 14.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified12
PHASE41
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT02013986PHASE4UNKNOWNEffects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children
NCT06111872PHASE2COMPLETEDKetamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
NCT05620485Not specifiedNOT_YET_RECRUITINGTiming of Operation in Children With a Prenatal Diagnosis of Choledochal Cyst
NCT06881004Not specifiedRECRUITINGBiliary Dilatation National Special Disease Cohort in China
NCT07036848Not specifiedRECRUITINGEfficacy and Safety of Surgical Treatment for Type IVa CBD
NCT07152496Not specifiedNOT_YET_RECRUITINGHost-Microbe Interactions in Biliary Dilatation
NCT07530354Not specifiedRECRUITINGA Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction
NCT02801500Not specifiedUNKNOWNSuperior Bilioenteric Anastomosis by Magnetic Compressive Technique
NCT03774589Not specifiedUNKNOWNBilioenteric Anastomosis by Magnetic Compressive Technique
NCT04319302Not specifiedCOMPLETEDIsolated Vascularized Gastric Tube Biliary Enteric Drainage: A Paediatric Case Series Experience.
NCT05181332Not specifiedUNKNOWNPredictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
NCT06418490Not specifiedUNKNOWNThe Application of Digital Intelligent Diagnostic and Therapeutic Technology in Biliary Dilation Diagnosis
NCT06716762Not specifiedCOMPLETEDOpen vs. Laparoscopic Surgery for Pediatric Choledochal Cyst
NCT07028164Not specifiedCOMPLETEDClinical Features and Prognosis of Asymptomatic Biliary Dilatation

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
ETOMIDATE41
MIDAZOLAM41
PROPOFOL41
S-ETOMIDATE-11